TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: safety and maximum tolerated dosage
Endpoint domain: Adverse events/effects
Primary endpoint: Cycle outcomes in poor responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma pharmacokinetic parameters of PF-06650833
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited Local Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited Vaccine Related Adverse Events after Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited Vaccine Related Adverse Events after Dose 2
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory-confirmed influenza status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction rate of IL-6 serum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Change in Spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Hip BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of long-COVID Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time taken for successful intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to the Last Collection Time After Study Drug Administration (AUC Last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to Infinity After Study Drug Administration (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Post-Operative Ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentration of inflammatory and cerebrospinal biochemical markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to 50% pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Evaluation of Effectiveness on Nasal Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical and sub-cortical brain signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Absolute Change in TBF-12 Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absolute Change in TSSw Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: surgical site infection incidence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of critical events where neonatal caregivers wash their hands with soap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily reduction in household soap weight
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of subjects reporting local reactions and their severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reporting systemic reactions and their severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reporting AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with abnormal hematology and blood chemistry assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Post-operative pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appearance of Surgical Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in optic nerve sheath diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Self-Report of Adequate Relief of Dyspepsia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: movements of finger tapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant Tumor Necrosis (STN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perceived improved family well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Public Speaking Self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of urine congophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of HbA1c measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in HHS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in T-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants receiving face mask PPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average Daily Dose of Oxymorphone Extended-Release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Ki-67-Stained Nuclei in Normal Rectal Mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Consumption (IV Morphine Equivalents)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV Self-sampling uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Patients Without Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency Department Arrivals Under 30 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECPR Initiations Under 30 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of sedation required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior chamber cell count of zero
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Exact lesion location in the thalamus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Beck's Depression Inventory Scale (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) Continuous Pain Subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of the medication
Endpoint domain: Adverse events/effects
Primary endpoint: Change in CRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Inspiratory and expiratory muscle strength (MIP, MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Lesion Counts (LCs) From Baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With a Minimum 2-grade (G) Improvement in the Investigator Static Global Assessment (ISGA) Score From Baseline at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With an ISGA Score of 0 or 1 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rehospitalization for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Overall Complete and Partial Response (CR+PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the mean deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of the visual field index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean total RSA measured migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent Distance From the Sex-age Specific 95th Percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gallbladder wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRA image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival Without BPD at 36 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: α-Klotho protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adipocyte endocrine function (leptin, adiponectin, and resistin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Receipt of CRC Screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Left Atrial Wall Thickness on ICE/IVUS Frames
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Atrial Wall Thickness on CT Scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak oxygen uptake (pVO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Attention to Response Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Multidimensional Assessment of Interoceptive Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Serum Concentration-Time Curve for Parathyroid Hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Amount of Calcium Excreted in Urine From Time 0 to 6 Hours Post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Parental Empowerment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Parental Knowledge about adult services questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Advocacy Skills and Comfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum plasma concentration of unconjugated Rotigotine (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from zero up to the last analytically quantifiable concentration of unconjugated Rotigotine (AUC 0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic veins diameter (in mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic artery diameter (in mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal vein diameter (in mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of at Least One Study-emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Blood test outcomes on day 4 during chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Morphological bone marrow examination following chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline KT-1000 Knee Laxity at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline KOOS at 24 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity and specificity of the COR-DIAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Rating Scale of Depression (HRSD-24)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SALT score (Severity of Alopecia Tool score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of montelukast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of montelukast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Physical activity levels - physical activity monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Physical activity levels - Human Activity Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Mobility - Gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Mobility - TEMPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Insulin medicated glucose disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with Infectious Postoperative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Men Achieving 5% Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain Scale (Numerical Rating Scale for Pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Asthma-related Hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Asthma-related Emergency Department (ED) Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Combined Hospitalizations/ED Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in LVEDV from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unresolved ophthalmic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Stiffness Measurement (Newtons)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation with muscular defects on pelvic MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation with subjective clinical assessment and symptom questionnaires (EPAQPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Tregs Infusion Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Kidney Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes In Steroid Resistance Rejection Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infectious Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal laboratory changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of specific biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Center for Epidemiologic Studies Depression Scale (CESD) score from baseline
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Epworth Sleepiness Scale (ESS) score from baseline
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Fatigue Severity Scale (FSS) score from baseline
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fugl-Meyer Assessment in upper & lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death from all causes at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Toxicities associated with chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (PR or CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: platelet response to clopidogrel treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: post-treatment platelet reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolic dysregulation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Total Number of Errors on the Groton Maze Learning Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in objective ocular signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AOFAS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in VAS pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Upper Extremity Fugl Meyer Motor Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Progression Free Survival at 3 Months
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) With Grade Greater Than or Equal to (>=) 3
Endpoint domain: Adverse events/effects
Primary endpoint: Self-reported risk behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Energy Purchased as a Result of Taxes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Energy Purchased as a Result of Subsidies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Volumetric hard tissue formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in metabolic risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: integrin expression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clearance of all AKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global End-Diastolic Volume Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum creatine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of LEAP Participants With Peanut Allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Younger Siblings With Peanut Sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients who received a second dose of influenza vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean Hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Efficacy of allogenic BMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paracentesis free survival
Endpoint domain: Mortality/survival
Primary endpoint: Peripheral blood mononuclear cells (PBMC) gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale for the Assessment of Positive Symptoms (SAPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strain Resistance of the Conjunctiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cerebellar Cognitive Affective Syndrome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trail-Making Test Part A and B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroop Color-Word Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Emotion Attribution impairment in SCA3/MJD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Progression-Free Survival (PFS) at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of gastric cancer or high grade dysplasia
Endpoint domain: Mortality/survival
Primary endpoint: Changes in Oral Inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Sputum Inflammatory Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Gut Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic Odds Ratio for MRI vascular cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Atrophy degree measurement (temporal muscle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Standardized uptake values (SUVs) of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between histological prediction and final histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Active Knee Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in creatine kinase (CK) levels in blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in Delayed Onset Muscle Soreness (DOMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical cure rate on Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of the signs and symptoms of stroke
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urinary Calcium Phosphate Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and efficacy of Somatostatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Relapse Rate
Endpoint domain: Mortality/survival